Home » Topics » Regulatory » EMA

EMA
RSS

GSK receives CHMP positive opinion for Volibris

Feb. 25, 2008

EMEA recommends that new warnings be included in product information for Novartis' Sebivo

Feb. 19, 2008

Lenalidomide approved in Australia and Canada, receives negative opinion in Europe

Jan. 29, 2008

EMEA issues opinion on safety of Gardasil

Jan. 29, 2008

EMEA recommends approval of novel oral anticoagulant, Pradaxa

Jan. 28, 2008

EMEA recommends suspension of marketing authorization of medicines containing aprotinin

Nov. 23, 2007

Novartis withdraws application to extend marketing authorization for Zometa

Nov. 22, 2007

MSD's Isentress for HIV-1 infection gets positive opinion from CHMP

Nov. 21, 2007

CHMP recommends Merck, Sharp and Dohme's Ivemend for nausea with chemotherapy

Nov. 21, 2007

Abbott voluntarily withdraws E.U. marketing authorization for Trudexa

Aug. 1, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...